GE Researchers Will Use $900K NHGRI Grant to Develop Single-Molecule Next-Gen Sequencer | GenomeWeb
NEW YORK (GenomeWeb News) — When the National Human Genome Research Institute announced its grant awards this fall for 11 research groups working on innovative sequencing technologies, one big name stuck out: General Electric.
 
The company, whose GE Healthcare division has been selling Amersham Biosciences’ MegaBace sequencing technology since GE acquired Amersham in early 2004, has until now remained quiet about whether it is pursuing next-generation sequencing.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.